Discussion postHiv aids

Drug Treatments For HIV/AIDS Discussion

Three tasks, and the first hides a confound. More people living with HIV is partly the effect of treatment keeping people alive, so prevalence rising is not on its own evidence of complacency.

Editorial process

Last reviewed · August 22, 2026

Written by

Maren Caldwell

MSN, RN, CNE

Medical-surgical nursing, pharmacology and NCLEX preparation

Reviewed by

Dr. Tessa Redmond

DNP, RN, CNE

Evidence-based practice and clinical education

On this page

Interpret the task
Assignment instructions
Deliverables
Proposed outline
Research plan
Reference shortlist
Final review

Why rising prevalence is not evidence of complacency

The first task looks like an opinion question and is actually a reasoning trap, so handle it carefully and you have most of the post. The brief observes that the number of people living with HIV in the United States is higher than it has ever been, and invites you to attribute that to complacency. But prevalence counts people living with a condition, and effective antiretroviral therapy has turned a fatal illness into a manageable chronic one. Fewer deaths mechanically raise prevalence even if new infections fall. So the measure that would actually test the complacency claim is incidence, not prevalence, and saying so is the single most valuable sentence you can write here. The instructor is not testing whether you disapprove of complacency; they are testing whether you can tell an epidemiological measure from a behavioural claim, and the two figures the brief quotes are exactly the pair that makes those come apart.

Having named the confound, you can still take the complacency question seriously, because something real sits behind it: reduced perceived severity does affect risk behaviour, and there is a genuine literature on treatment optimism. Weigh it against the countervailing evidence that an undetectable viral load prevents sexual transmission, which means widespread treatment lowers transmission rather than raising it. That is the fact the perception half of the prompt should be built on, because the misperception worth correcting is not that HIV has become trivial but that it remains untreatable and shameful, which is what keeps people from testing. Then make the adherence strategies concrete: simplified once-daily regimens, pharmacy refill monitoring, reminder systems, addressing depression and substance use as adherence barriers, and stigma-aware conversation. Say what resistance costs: it narrows the regimens available to that patient for the rest of their life, not just the effect of the current one.

Likely learning objectives

Distinguish prevalence from incidence when testing a causal claim.
Weigh treatment optimism evidence against transmission prevention evidence.
Identify the misperception actually worth correcting.
Propose adherence strategies that address real barriers rather than knowledge alone.

Assignment instructions

Read the full question

Review every instruction before using the planning guidance that follows.

Needs 3 reference sources above 2013 in APA. While HIV/AIDS is still currently incurable, the prognosis for patients with this infectious disease has improved due to advancements in drug treatments. Consider the case of Kristy Aney. Kristy was diagnosed with HIV in 1992 and was told she would survive, at most, 10 more years. Despite unfavorable odds, Kristy is still alive 20 years later. Since her diagnosis, she has witnessed tremendous improvements in HIV/AIDS treatments which have helped patients live longer with fewer side effects. While she acknowledges that these drug treatments have kept her alive, she fears that improvements in drug therapy have led to more people becoming complacent about the disease (Idaho Statesmen, 2012). In fact, the number of people living with HIV/AIDS in the United States is higher than it has ever been (CDC, 2012). This poses the question: Is there a relationship between drug advancements, societal complacency, and infection? To prepare: Review Chapter 49 of the Arcangelo and Peterson text, as well as the Krummenacher et al. and Scourfield articles in the Learning Resources. Reflect on whether or not the prevalence of HIV cases might be attributed to increased complacency due to more advanced drug treatment options for HIV/AIDS. Consider how health care professionals can help to change perceptions and make people more aware of the realities of the disease. Think about strategies to educate HIV positive patients on medication adherence, as well as safe practices to reduce the risk of infecting others. With these thoughts in mind: By Day 3 Post an explanation of whether or not you think the prevalence of HIV cases might be attributed to increased complacency due to more advanced drug treatment options.Then, explain how health care professionals can help to change perceptions and increase awareness of the realities of the disease. Finally, describe strategies to educate HIV positive patients on medication adherence, as well as safe practices to reduce the risk of infecting others. Review Chapter 49 of the Arcangelo and Peterson text, as well as the Krummenacher et al. and Scourfield articles in the Learning Resources.

Turn the brief into deliverables

01An explanation of why prevalence rises when survival improves.
02A statement of which measure would test the complacency claim.
03The undetectable equals untransmittable evidence, stated accurately.
04Strategies for changing perception, aimed at a named misperception.
05Adherence strategies addressing structural and psychological barriers.
06Safe practice guidance for reducing transmission risk.
07Three references published after 2013.